ArticleDiagnostics (Basel, Switzerland)2023
Hormonal and Metabolic Factors Influence the Action of Progesterone on the Endometrium of Women with Polycystic Ovary Syndrome.
Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Non-linear saturation threshold of gonadotropin dose on cumulative live birth rates in advanced-age women with polycystic ovary syndrome: a retrospective cohort study.Frontiers in endocrinology · 2026Article
- The discriminative role of angiopoietin-like protein-3 for metabolic syndrome in polycystic ovary syndrome.Revista da Associacao Medica Brasileira (1992) · 2026Article
- Evaluation of serum soluble triggering receptor expressed on myeloid cells-1 in polycystic ovary syndrome.Revista da Associacao Medica Brasileira (1992) · 2026Article
- Investigation of serum agouti-related peptide levels in women with polycystic ovary syndrome.Revista da Associacao Medica Brasileira (1992) · 2025Article
- Role of atherogenic indices in predicting infertility in polycystic ovary syndrome.Revista da Associacao Medica Brasileira (1992) · 2025Observational
- GnRH agonist pretreatment in hormonal endometrial preparation: a comparison of two protocols for frozen embryo transfer outcomes.Frontiers in medicine · 2025Article
- The relationship between spexin and liver steatosis in polycystic ovary syndrome: a novel analysis using ultrasound-guided attenuation parameter.Revista da Associacao Medica Brasileira (1992) · 2025Article
- Obstructive sleep apnea risk and sleep quality in adolescents with polycystic ovary syndrome: a case-control study.Revista da Associacao Medica Brasileira (1992) · 2025Article
- Polycystic ovary syndrome: emerging stem cell therapies.Revista da Associacao Medica Brasileira (1992) · 2024Article
- Is polycystic ovary syndrome a risk factor for depression and anxiety?: a cross-sectional study.Revista da Associacao Medica Brasileira (1992) · 2024Article
- Effect of polycystic ovary syndrome on the life quality of young women.Revista da Associacao Medica Brasileira (1992) · 2024Article
- The association of CYP11A1 gene polymorphisms with the polycystic ovary syndrome patients.Revista da Associacao Medica Brasileira (1992) · 2024Article
- Influence of Phenotypes on the Metabolic Syndrome of Women with Polycystic Ovary Syndrome over a Six-Year Follow-Up in Brazil.Biomedicines · 2023Article
- Dysregulation of immune response in PCOS organ system.Frontiers in immunology · 2023Review
- Breast cancer survivals and hormone therapy: estrogen and melatonin.Revista da Associacao Medica Brasileira (1992) · 2023Article
- Association of polycystic ovary syndrome with mammographic density in Turkish women: a population-based case-control study.Revista da Associacao Medica Brasileira (1992) · 2023Article
- Women health: holistic view.Revista da Associacao Medica Brasileira (1992) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Hormonal and metabolic factors may influence endometrial quality and interfere with the action of progesterone. Therefore, the aim of our study was to address this issue. Participants were recruited from an outpatient reproductive endocrinology clinic at an academic tertiary medical care centre. All subjects underwent endometrial biopsy (EB) in the follicular phase of the cycle prior to treatment. Thereafter, they were treated with micronized progesterone (400 mg/day × 10 days intravaginally) from days 14-28 of the next cycle. A second EB was performed between days 21-24 of the cycle (the second phase). The metabolic and hormonal serum levels were evaluated during the implantation window. EB samples were analysed using light microscopy for histomorphometric analysis. The endometrium of women with Polycystic Ovarian Syndrome (PCOS) in the second phase demonstrated a uniform surface epithelium with less leukocyte infiltration and an absence of apoptotic figures compared to the control group. (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.